Canopy Growth Corporation vs Pfizer, Inc. — Stock Comparison

CGC
Canopy Growth Corporation
$1.13
▲ 1.80%
vs
PFE
Pfizer, Inc.
$26.33
▼ 1.39%
Q·Score Winner
Pfizer, Inc.
PFE6.5/10vs 4/10

Q·Score Breakdown

4
Bearish
Overall
6.5
Neutral
0.2
Quality
7.4
8.2
Health
7
3
Growth
5.6
6.3
Valuation
6.7
3.3
Sentiment
5.2
CGC

Clean balance sheet with low leverage (0.3× debt-to-equity).

currently unprofitable (-117% margin).

PFE

Strong profitability with 12% net profit margins.

analyst sentiment is cautious.

Analyst Consensus

HOLD
Target $1.81 (+60.0%)
1 analysts
HOLD
Target $29.00 (+10.2%)
27 analysts

Fundamentals

CGC
PFE
Trailing P/E
19.4×
-15.5×
Forward P/E
9.4×
-117.3%
Profit Margin
12.4%
26.6%
Gross Margin
75.8%
-48.5%
ROE
8.9%
-0.3%
Revenue Growth
-1.2%
Earnings Growth
2.32
Beta
0.39
Price / Book
$507M
Market Cap
$149.8B
$1 – $2
52-Week Range
$22 – $29

Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →